Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension
- PMID: 9433512
- DOI: 10.1007/978-1-4615-5385-4_7
Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension
Abstract
Left ventricular hypertrophy (LVH) is a common finding in hypertension and represents a detrimental outcome since it is associated with increased morbidity and mortality. For similar elevation of blood pressure the severity and type of LVH vary considerably in relation to several factors. Compelling evidence suggests that both the renin-angiotensin system (RAS) and the aldosterone excess play an important role in the pathogenesis of LVH, since experimentally angiotensin II has been found to cause myocardial cells hypertrophy and/or hyperplasia and excess aldosterone has been related to extracellular matrix and collagen deposition and therefore to myocardial fibrosis. Secondary forms of hypertension offer models for investigating the relative role of the RAS and aldosterone on the heart in humans. Being rare in the population of hypertensive patients, they furnish an example of the so called Bateson's approach to the understanding of diseases "Treasure your exceptions." In this paper, we review the data concerning the LV changes in primary aldosteronism and renovascular hypertension and discuss the insight that they have provided into the pathogenesis of LVH.
Similar articles
-
Role of aldosterone in left ventricular hypertrophy in hypertension.Am J Hypertens. 2006 Jan;19(1):13-8. doi: 10.1016/j.amjhyper.2005.05.013. Am J Hypertens. 2006. PMID: 16461184
-
Cardiac consequences of aldosterone excess in human hypertension.Am J Hypertens. 2006 Jan;19(1):10-2. doi: 10.1016/j.amjhyper.2005.08.011. Am J Hypertens. 2006. PMID: 16461183 No abstract available.
-
[Left ventricular myocardial structure and function in patients with primary aldosteronism].Ter Arkh. 1999;71(9):13-9. Ter Arkh. 1999. PMID: 10553618 Russian.
-
The renin-angiotensin-aldosterone system in primary and secondary hypertension.Ann Clin Lab Sci. 1981 Nov-Dec;11(6):497-505. Ann Clin Lab Sci. 1981. PMID: 6119955 Review.
-
Secondary aldosteronism.Endocrinol Metab Clin North Am. 1995 Sep;24(3):511-29. Endocrinol Metab Clin North Am. 1995. PMID: 8575407 Review.
Cited by
-
Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease.Am J Nephrol. 2009;29(3):213-21. doi: 10.1159/000156715. Epub 2008 Sep 17. Am J Nephrol. 2009. PMID: 18797164 Free PMC article.
-
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.Vasc Health Risk Manag. 2017 Oct 16;13:403-411. doi: 10.2147/VHRM.S138599. eCollection 2017. Vasc Health Risk Manag. 2017. PMID: 29081661 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical